Skip to Main Content

Paper Details

Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.
Oncologist
6
2021
Glioblastoma, NTRK, NTRK2, NTRK2-rearranged isocitrate dehydrogenase-wild-type glioblastoma, NTRK2-rearranged tumor cell clones, PDGFRA, PDGFRA-amplified subclone, Receptor Tyrosine Kinase, Tyrosine, fusion gene, glioblastoma, isocitrate, isocitrate dehydrogenase, larotrectinib, man, neurotrophic receptor tyrosine kinase, neurotrophic receptor tyrosine kinase (NTRK) gene family, rare cells, receptor tyrosine kinase genes, receptor tyrosine kinases, tumor, tyrosine
Author NameAffiliation
Maria Martinez-LageMassachusetts General Hospital, Harvard Medical School
Maria Martinez-LageMassachusetts General Hospital, Harvard Medical School
Anat Stemmer-RachamimovMassachusetts General Hospital, Harvard Medical School
Anthony J IafrateMassachusetts General Hospital, Harvard Medical School
  • 1 - 4

Datasets

Release 1.2